My Profile
Edit Profile
My Follows
My Wires
My Drafts
Analytics
Email Preferences
Sign Out
home
Latest
Shares
ETFs
Infrastructure
Markets
Buy Hold Sell
Topics
Alternatives
Exchange Traded Funds (ETFs)
Growth
Income
Markets
Property
Retirement
Shares
Wealth
Shows
Ask an Adviser
Buy Hold Sell
Expert Insights
Fund in Focus
Rapid Fire
Success and More Interesting Stuff
The Rules of Investing
Series
Listed Series
Livewire Live
Meet The Investor
Outlook Series
Reporting Season
Contributors
Find Funds
Newsletter
About Livewire
Advertising
Careers
Contact Us
Write a Wire
Notifications
Loading...
Write a wire
Account
My profile
My follows
My wires
My drafts
Analytics
Email preferences
Company
About Livewire
Advertising
Contact us
Sign out
Sign In
Join Free
Latest
Shares
ETFs
Infrastructure
Markets
Buy Hold Sell
Find funds
Newsletter
Topics
Alternatives
Exchange Traded Funds (ETFs)
Growth
Income
Markets
Property
Retirement
Shares
Wealth
Shows
Ask an Adviser
Buy Hold Sell
Expert Insights
Fund in Focus
Rapid Fire
Success and More Interesting Stuff
The Rules of Investing
Series
Listed Series
Livewire Live
Meet The Investor
Outlook Series
Reporting Season
Categories
Asset Allocation
Commodities
Daily Report
Education
Equities
Fixed Income
Funds
Investment Theme
Macro
Private Markets
Property
Weekend Report
Find Funds
Contributors
Newsletter
About Livewire
Advertising
Careers
Contact Us
Market Wraps
FEBRUARY 2026 REPORTING SEASON
Latest news and analysis on FEBRUARY 2026 REPORTING SEASON
Reporting Season
February 13, 2026 08:27
Reporting season cheat sheet: what to watch at results time
Reporting season is like speed dating: these sector KPIs can help you determine who’s worth a second date (and who’s bluffing).
Chris Conway
Livewire Markets
February 13, 2026 08:27
Reporting Season
February 12, 2026 15:22
Debt-free and still delivering: Why WAM is backing Pro Medicus despite big sell-off
PME dropped more than 20% on revenue and dividend misses, even as NPAT soars to $171m.
PME
Pro Medicus Ltd
ASX:PME
Followed by
374
people
PME
Pro Medicus Ltd
ASX:PME
Followed by
374
people
Tom Stelzer
Livewire Markets
February 12, 2026 15:22
Reporting Season
February 12, 2026 14:30
10 consecutive halves of customer growth as the Origin story rolls on
Retail strength, data centre demand and rising power prices could reshape Origin’s earnings trajectory.
ORG
Origin Energy Ltd
ASX:ORG
Followed by
377
people
ORG
Origin Energy Ltd
ASX:ORG
Followed by
377
people
Stephanie Gardner
Livewire Markets
February 12, 2026 14:30
Advertisement
Reporting Season
February 11, 2026 10:26
"No longer a blue-chip" - CSL's fall from grace plunges new depths
Marcus Today’s Henry Jennings is unimpressed by CSL’s results - and even less so by its handling of the CEO change.
CSL
CSL Ltd
ASX:CSL
Followed by
1590
people
CSL
CSL Ltd
ASX:CSL
Followed by
1590
people
Vishal Teckchandani
Livewire Markets
February 11, 2026 10:26
Reporting Season
February 06, 2026 15:58
FNArena reporting season monitor: Feb 2026 - Week 1 (11 stocks covered)
Read on to find the ratings, consensus price targets, and FNArena insights on each stock covered.
Rudi Filapek-Vandyck
FNArena
February 06, 2026 15:58
Reporting Season
February 05, 2026 14:30
Amcor a BUY for IML's Daniel Moore as he looks to second half improvement
Amcor’s result wasn’t strong, but it didn’t need to be. Why “less bad” was enough to lift the stock, and what matters from here.
AMC
Amcor Plc
ASX:AMC
Followed by
1269
people
AMC
Amcor Plc
ASX:AMC
Followed by
1269
people
Chris Conway
Livewire Markets
February 05, 2026 14:30
31-36 of 36
1
2
3
4
most
popular
Equities
Question everything
Martin Conlon,
Schroders
Alternatives
Why Magellan is "unashamedly conservative" on infrastructure and the ASX stock they
like
Tom Stelzer,
Livewire Markets
Markets
What pre-IPO perps are saying about the Anthropic float
Keith Ford,
Livewire Markets
Equities
Five rate hikes later, real income is still growing
Andrew Chambers,
ClearBridge Investments
view all
Advertisement